This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO

Park Square is so pleased to have been of service to the Deep Genomics Board of Directors. Congratulations to Brian, Brendan, and Chip on their new roles! 

“I am impressed with the work underway at Deep Genomics and see tremendous opportunity to build on the technology innovations spearheaded by Brendan and the team to achieve value for patients, partners and investors”

Tags

jessehershman, ai, rnatherapeutics, executivesearch, leadership, ceo, drugdiscovery, eriklundh, insights, news, life sciences